glucose, (beta-d)-isomer has been researched along with Benign Neoplasms in 114 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 34 (29.82) | 18.7374 |
| 1990's | 3 (2.63) | 18.2507 |
| 2000's | 15 (13.16) | 29.6817 |
| 2010's | 37 (32.46) | 24.3611 |
| 2020's | 25 (21.93) | 2.80 |
| Authors | Studies |
|---|---|
| HERBUT, PA; KRAEMER, WH | 1 |
| JUDE, JR; SCHATTEN, WE | 1 |
| BRADNER, WT; CLARKE, DA; STOCK, CC | 1 |
| BERNDT, H; HEISE, E; LUHRS, W | 1 |
| BRADNER, WT; CLARKE, DA | 1 |
| NAGY, I; PUTNOKY, G | 1 |
| HARTAI, F; NAGY, S | 1 |
| SZABO, IK | 1 |
| JENO, A; NAGY, IS | 1 |
| DILLER, IC; FISHER, ME; MANKOWSKI, ZT | 1 |
| ISHIBASHI, Y | 1 |
| KOSZORU, M; MAJOROSSY, K; NAGY, I; VAJDA, J | 1 |
| IMANAGA, H | 1 |
| FUJII, K; SATO, H; SATOH, H | 1 |
| OMORI, Y | 1 |
| MARTIN, DS | 1 |
| MCCONNELL, B; SOKOLOFF, B | 1 |
| ATS, M; KOSZORU, M; LUST, I; NAGY, IS | 1 |
| AOKI, T; ROBITAILLE, ML; TELLER, MN | 1 |
| KOSSEY, P; ORAVEC, C; SMIDOVA-KOVAROVA, V | 1 |
| Cron, J; Jansa, P | 1 |
| Becker, S; Haskill, S; Johnson, T; Marro, D; Nelson, K; Propst, RH | 1 |
| Allgöwer, M; Dürig, M; Ernst, M; Fischer, H; Heberer, M | 1 |
| Dobrek, A; Maciejewski, B; Majewski, S | 1 |
| Blumenson, L; Krasner, J; Müller, S; Ozer, H | 1 |
| Dürig, M; Ernst, M; Harder, F; Heberer, M; Zbinden, AM | 1 |
| Mathé, G | 1 |
| Isliker, H; Kliem, U; Leuchtenberger, C | 1 |
| Dobrek, Z; Maciejewski, B; Majewski, S | 2 |
| Bramberga, VM; Kundzinia, IA; Zitare, II | 1 |
| Jenö, A; Nagy, I | 1 |
| Li, WH; Tian, Y; Wang, XP; Yuan, DY | 1 |
| Akour, A; Al-Tammemi, AB; AlMuhaissen, SA; Alrawashdeh, MN; An, H; Anastasia, L; Apkon, S; Armstrong, WS; Ayala Izurieta, JE; Barnett, K; Bhowmick, S; Biniskos, N; Booka, E; Brown, JC; Buchanan, SW; Campbell, C; Camporeale, A; Cantos, VD; Cao, Z; Chakraborty, RD; Chaturvedi, V; Chen, C; Chen, G; Chen, Y; Chou, PT; Ciconte, G; Colasanti, JA; Collins, LF; Darras, BT; de Carvalho, RM; De Morais, DC; Delegido, J; Dodd, J; Doki, Y; Dunfield, K; Elfring, G; Feng, B; Ferry, VE; Galaviz, KI; García, VJ; Greven, M; Guo, J; Gutierrez, M; Hameed, S; Hippler, M; Huang, JW; Isaac, ME; Ishihara, R; Ishikawa, H; Ito, Y; Jacobson, A; Jalouqa, S; James, TD; Jara Santillán, CA; Jiang, K; Jordan, R; Kampf, JW; Kato, H; Kato, K; Katzmarzyk, PT; Kaviani, A; Kawachi, H; Kawakubo, H; Khansari Nejad, N; Kitagawa, Y; Kojima, T; Kono, K; Koplowitz, B; Kubo, Y; Kuribayashi, S; Lahiri, CD; Lei, H; Leighton, C; Li, J; Liu, G; Lombardi, M; Lu, Y; Luo, Y; Ma, P; Mafa-Attoye, T; Mahmoud, NN; Makhlina, M; Makino, T; Manguso, F; Mano, M; Manso, AP; Marconi, VC; Márquez, CO; Matsubara, H; Matsuda, S; McDonald, CM; Mecarocci, V; Metcalfe, GD; Micaglio, E; Miele, L; Mire, EF; Miyazaki, T; Moi, CT; Moore, CM; Moran, CA; Muto, M; Nemoto, K; Nguyen, ML; Nusair, MB; Ochoa, A; Owen, G; Oyama, T; Palma-Dibb, RG; Pappone, C; Parsons, JA; Pasqualotto, N; Peltz, SW; Pesco Koplowitz, L; Pica, S; Postiglione, WM; Qureshi, M; Rhodes, J; Saeki, H; Sakai, M; Santinelli, V; Santos, C; Shah, NS; Shanahan, JP; Shieh, PB; Sisti, JM; Smith, TW; Sohda, M; Song, Y; Spana, C; Sturla, F; Su, BK; Sumitani, J; Szabo, B; Szymczak, NK; Tabiś, W; Takeuchi, H; Tang, X; Thevathasan, NV; Toh, Y; Tondi, L; Trifillis, P; Tsushima, T; Van Wittenberghe, S; Vicedomini, G; Wang, H; Wang, K; Wang, S; Wang, W; Wang, X; Wang, Y; Wu, F; Wu, X; Yamaji, T; Yamamoto, K; Yamatsuji, T; Yang, L; Yang, S; Yang, WH; Yang, Y; Yoshida, M; Yu, B; Yuan, L; Zabaleta, J; Zhang, C; Zhang, H; Zhang, L; Zhang, X; Zhang, Z; Zheng, WQ; Zheng, YX; Zhou, H; Zhou, J; Zhou, N; Zhu, W | 1 |
| Cuong, NX; Hanh, TTH; Quang, TH; Vinh, LB | 1 |
| Chen, Q; Li, X; Mou, Y; Wang, T; Wang, XZ; Xia, L; Zhang, XY; Zhang, YN | 1 |
| Gong, F; Hu, J; Liu, J; Liu, T; Yang, J; Zhang, S | 1 |
| Kanellakis, M; Velesiotis, C; Vynios, DH | 1 |
| Alomar, SY; Hashmi, MA; Imran, MA; Qais, FA | 1 |
| He, Q; Hu, G; Li, X; Liang, Z; Lin, M; Miu, Q; Xia, J; Ye, F; Yu, J; Zeng, Z; Zhang, X | 1 |
| Bayat, Z; Taherkhani, A; Tarokhian, A | 1 |
| Bishayee, A; Ganguly, R; Gupta, A; Kumar, R; Pandey, AK; Pandey, PK; Rana, HK; Sethi, G; Singh, AK | 1 |
| Ding, ZT; Hu, JM; Jiang, ZH; Kong, QH; Li, HM; Yang, L; Yang, XZ; Zhou, J; Zi, CT | 1 |
| Gao, Y; Huang, C; Li, Z; Wei, S; Xiang, Y; Zhang, Q | 1 |
| Cheng, Y; Fang, L; Li, E; Li, X; Shabir, G; Xu, L; Zhang, H | 1 |
| Abhinand, CS; Athira, PA; Soumya, SJ; Sudhakaran, PR | 1 |
| Kamal, MA; Nagaraju, GP | 1 |
| Koert, U; Maza, HLD; McGaw, LJ; Mfotie Njoya, E; Mkounga, P; Nkengfack, AE | 1 |
| Beale, MH; Cinatl, J; Corol, D; Harflett, C; Lomax, C; Macalpine, WJ; Michaelis, M; Onafuye, H; Ward, JL; Wass, MN; Wu, Y | 1 |
| Gollapalli, BP; Gorantala, J; Magani, SKJ; Mupparthi, SD; Shukla, D; Tantravahi, S; Tiwari, AK; Yarla, NS | 1 |
| Fu, Q; Gu, Z; Jin, X; Lv, H; Zhang, Z | 1 |
| Wright, EM | 1 |
| Chen, J; Hu, X; Lin, J; Sui, X; Wang, X; Xia, Y; Zhang, J; Zhang, Z; Zhou, Z | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Adem, Ş; Adnan, M; Asrar, M; Hussain, G; Khalid, R; Nageen, B; Rasul, A; Riaz, A; Sarfraz, I; Sarker, SD; Selamoglu, Z; Shah, MA | 1 |
| Du, M; Gao, P; Gu, L; Liu, Q; Liu, S; Shen, S; Wang, J | 1 |
| Augello, G; Azzolina, A; Cervello, M; Cusimano, A; Di Stefano, V; Emma, MR; Giannitrapani, L; Montalto, G | 1 |
| Borghoff, SJ; Chappell, GA; Doepker, CL; Heintz, MM; Wikoff, DS | 1 |
| Abd Elmaaboud, MA; Arab, HH; Kabel, AM | 1 |
| Li, X; Liu, K; Long, J; Xie, L; Xie, Q; Zhang, X; Zheng, Y | 1 |
| Abed, B; Chaaban, H; Ghedira, K; Ghedira, LC; Ghoul, M; Iaonnou, I; Maatouk, M; Mokdad-Bzeouich, I; Mustapha, N | 1 |
| Dai, Q; Han, J; Shi, W; Song, Y; Tang, H; Zhai, S | 1 |
| Brauhli, G; Katsarou, O; Mihailidou, C; Moutsatsou, P; Panagiotou, C | 1 |
| Das, A; Kumar, GS | 1 |
| Aquino, G; Arra, C; Barbieri, A; Boocock, D; Caraglia, M; Coveney, C; Desiderio, V; La Noce, M; Liccardo, D; Lombardi, A; Mele, L; Paino, F; Papaccio, F; Papaccio, G; Regad, T; Stiuso, P; Tirino, V | 1 |
| Inzucchi, SE; Lupsa, BC | 1 |
| Brunetti, L; Chiavaroli, A; Ferrante, C; Leone, S; Leporini, L; Menghini, L; Orlando, G; Recinella, L | 1 |
| Chen, L; Lu, F; Wan, JY; Wang, CZ; Yuan, CS; Zhang, CF | 1 |
| Dicembrini, I; Mannucci, E; Monami, M; Nreu, B | 1 |
| Ejadi, S; Gnjatic, S; Kenney, R; Kim-Schulze, S; Lu, H; Mahipal, A; Odunsi, K; Ter Meulen, JH | 1 |
| Aliani, M; Austria, JA; Maddaford, TG; Netticadan, T; Parikh, M; Pierce, GN | 1 |
| Ohki, T; Sata, M; Shibata, H; Sumi, M; Tateishi, N | 1 |
| Li, GT; Li, Y; Liu, HY; Ni, W; Yan, H; Zhang, XD; Zhong, HM | 1 |
| Agi, E; Alizadeh, F; Balaram, P; Bathaie, SZ; Bolhassani, A; Khavari, A; Vahabpour, R | 1 |
| Goyal, AK; Lubna, S; Middha, SK; Mohan, TM; Pande, V; Prashanth, H; Usha, T | 1 |
| Andrade, SF; Araújo, PA; Maistro, EL; Marques, Ede S; Niero, R; Perazzo, FF; Petreanu, M; Rosa, PC; Tolentino, F | 1 |
| Ban, NK; Cuong, NT; Cuong, NX; Diep, CN; Hanh, TH; Huong, PT; Kiem, PV; Minh, CV; Nam, NH; Thai, TH; Thanh, NV; Thao, do T; Thao, NP; Tu, VA | 1 |
| Abdul Razak, AR; Bartha-Vári, JH; Boros, Z; Cai, S; Carlson, R; Chong, YS; Chua, SY; Dagis, A; Feng, X; Foo, VH; Gabrail, NY; Gerecitano, JF; Gluckman, P; Huber, S; Ikram, MK; Irimie, FD; Kauffman, M; Kim, R; Kwek, K; Landesman, Y; Lassen, U; Li, D; Li, Q; Liu, C; Ma, J; Mahipal, A; Mau-Soerensen, M; McCauley, D; Mirza, MR; Nademanee, A; Ngo, C; Paizs, C; Palmer, JM; Pizzari, T; Poppe, L; Rashal, T; Saint-Martin, JR; Saw, SM; Shacham, S; Shields, AF; Stayner, LA; Tan, CS; Thorborg, K; Toşa, MI; Tsai, NC; Unger, TJ; Verkicharla, PK; Vértessy, BG; Wang, S; Wang, Y; Weiser, D; Wollin, M; Wong, TY; Xu, L; Yuan, L; Yuan, S; Zhang, Y; Zheng, R | 1 |
| Abian, O; López, V; Pérez, S; Vinuesa, A; Zorzetto, C | 1 |
| Bacchu, V; Elsaidi, HR; Kumar, P; Laurens, E; Wang, M; Wiebe, LI; Yang, J; Zorniak, B | 1 |
| Dudra, A; Gabrielska, J; Strugała, P | 1 |
| Chen, LH; Deng, Y; Gu, Y; Liu, SS; Ming, YL; Zheng, GH; Zheng, ZZ | 1 |
| Czigle, S; Falkay, G; Háznagy-Radnai, E; Martinek, T; Máthé, I; Réthy, B; Wéber, E; Zupkó, I | 1 |
| Cui, JR; Li, M; Li, ZJ; Ma, YX; Sun, W; Xu, B; Yang, YP; Yi, WY | 1 |
| Bokar, JA; Brell, JM; Cooney, MM; Cooper, B; Dowlati, A; Gibbons, J; Ivy, P; Krishnamurthi, S; Manda, S; Nock, CJ; Remick, SC; Savvides, P | 1 |
| Adolphe, JL; Alcorn, J; Juurlink, BH; Thorpe, LU; Whiting, SJ | 1 |
| Bidet, M; Joubert, O; Lacombe, B; Mus-Veteau, I; Nehmé, R; Polidori, A; Pucci, B | 1 |
| Li, W; Shi, H; Shi, Z; Wang, R; Yu, B; Zhou, B | 1 |
| Billings, KJ; Desmond, RT; Fenteany, G; Magpusao, AN; Peczuh, MW | 1 |
| Bai, N; Bily, A; He, K; Ho, CT; Lai, CS; Pan, MH; Roller, M; Shao, X | 1 |
| Chang, HW; Hwangbo, K; Kim, JR; Lee, CS; Lee, SK; Lee, YK; Li, Y; Son, JK; Zheng, MS | 1 |
| Azimova, SS; Egamberdieva, DR; El-Readi, MZ; Hamoud, R; Herrmann, F; Mamadalieva, NZ; Tahrani, A; Wink, M | 1 |
| Kashiwada, Y; Kurimoto, S; Lee, KH; Takaishi, Y | 1 |
| Wick, JY | 1 |
| Cheeseman, C; Khlebnikov, V; Kumar, P; Liang, H; Shustov, G; Wiebe, LI; Yang, XH; Zheng, W | 1 |
| Chang, HW; Hwangbo, K; Im, JY; Jahng, Y; Kim, YJ; Lee, CS; Son, JK; Woo, MH; Zheng, MS | 1 |
| Alberti, D; Arzoomanian, R; Binger, K; Cleary, J; Dresen, A; Feierabend, C; Marnoccha, R; Merchant, J; Thomas, J; Tutsch, K; Wilding, G | 1 |
| Forenza, S; Long, BH; Matson, JA; Rose, WC; Vyas, DM | 1 |
| Baruchel, S; Bernstein, M; Blaney, S; Furman, W; Kuhn, JG; Langevin, AM; Vietti, T; Weintraub, ST; Weitman, SD | 1 |
| Briedis, V; Kucinskaite, A; Savickas, A | 1 |
| Ayuso, MJ; Gálvez, M; Martín-Cordero, C | 1 |
| Berg, K; Forero, L; Forouzesh, B; Goetz, A; Hammond, LA; Kuhn, JG; Ochoa-Bayona, JL; Ricart, AD; Rowinsky, EK; Takimoto, CH; Tolcher, AW | 1 |
| Chen, PN; Chiang, CL; Chiou, HL; Chu, SC; Hsieh, YS; Yang, SF | 1 |
| Adamson, PC; Bernstein, M; Blaney, SM; Chen, Z; Ivy, P; Kuhn, JG; Langevin, AM; Sun, J | 1 |
| Germain, D; Hitomi, T; Kawanaka, M; Koyama, M; Matsuzaki, Y; Nishikawa, A; Sakai, T; Yokota, T | 1 |
| Eschmann, SM; Langen, KJ | 1 |
| Brady, RO; Gal, AE; Grimley, PM; Newmark, J; Thistlethwaite, JR; Waller, SG | 1 |
| Bailly, C; Lansiaux, A | 1 |
| Arakawa, H; Kodera, T; Morishima, H; Morita, M; Nishimura, S; Ohkubo, M; Okura, A | 1 |
| Dowlati, A; Gerson, SL; Hoppel, CL; Ingalls, ST; Ivy, P; Li, X; Majka, S; Remick, SC; Sedransk, N; Spiro, T | 1 |
| Aylesworth, C; Campbell, E; Eckhardt, SG; Felton, S; Hammond, L; Hidalgo, M; Kuhn, J; Patnaik, A; Rizzo, J; Rowinsky, EK; Schwartz, G; Tolcher, AW; Weiss, G | 1 |
| Ahmad, H; Miller, EG; Patil, BS; Tang, L; Tian, Q | 1 |
| Falkson, G; Falkson, HC; van den Bergh, JA; van der Merwe, AM; van Dyk, JJ; van Eden, EB | 1 |
| Qian, JK; Wang, BZ; Wen, XL; Yang, GH; Zhang, RJ | 1 |
22 review(s) available for glucose, (beta-d)-isomer and Benign Neoplasms
| Article | Year |
|---|---|
Active immunotherapy.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Antigens; Antigens, Neoplasm; Antineoplastic Agents; BCG Vaccine; Bordetella pertussis; Corynebacterium; Humans; Immunization; Leukemia L1210; Leukemia, Lymphoid; Leukocytes; Mice; Neoplasm Transplantation; Neoplasms; Oncogenic Viruses; Poly I-C; Polynucleotides; Remission, Spontaneous; Transplantation Immunology; Transplantation, Homologous; Zymosan | 1971 |
Topics: Adult; Alcohol Drinking; Ammonia; Animals; Anti-Inflammatory Agents; Area Under Curve; B-Lymphocytes; Black or African American; Bleaching Agents; Body Mass Index; Brugada Syndrome; Carbon; China; Climate Models; Codon, Nonsense; Cohort Studies; Colitis; Colon; COVID-19; Cytokines; Dental Enamel; Dextran Sulfate; Disease Models, Animal; Disease Outbreaks; Dogs; Electrocardiography; Escherichia coli; Esophageal Neoplasms; Female; Follow-Up Studies; Forests; Georgia; Glucosides; Healthy Volunteers; Heart Ventricles; Hesperidin; HIV Infections; Humans; Humidity; Hydrogen Peroxide; Incidence; Influenza, Human; Longitudinal Studies; Magnetic Resonance Imaging, Cine; Male; Melanocortins; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Middle Aged; Muscular Dystrophy, Duchenne; Naphthol AS D Esterase; Naphthols; Neoplasms; Nitrates; Nitrites; Nitrous Oxide; Obesity; Pandemics; Patient Outcome Assessment; Patient Satisfaction; Plants; Prednisolone; Prednisone; Pregnenediones; Proportional Hazards Models; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Rats; Receptor, Melanocortin, Type 1; Retrospective Studies; Risk Factors; SARS-CoV-2; Seasons; Soil; Stroke Volume; T-Lymphocytes; Telemedicine; Temperature; Tetralogy of Fallot; Tooth Bleaching; Tooth Bleaching Agents; Trees; Urea; White People | 2021 |
The multifaceted mechanisms of Paeoniflorin in the treatment of tumors: State-of-the-Art.
Topics: Glucosides; Humans; Monoterpenes; Neoplasms; Paeonia | 2022 |
Corilagin in Cancer: A Critical Evaluation of Anticancer Activities and Molecular Mechanisms.
Topics: Animals; Antineoplastic Agents; Biological Availability; Glucosides; Humans; Hydrolyzable Tannins; Models, Biological; Neoplasms; Signal Transduction | 2019 |
Paeoniflorin: a monoterpene glycoside from plants of Paeoniaceae family with diverse anticancer activities.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Proliferation; Colorectal Neoplasms; Glioma; Glucosides; Humans; Leukemia; Liver Neoplasms; Lung Neoplasms; Monoterpenes; Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms | 2020 |
Salidroside - Can it be a Multifunctional Drug?
Topics: Animals; Antineoplastic Agents; Diabetes Mellitus; Glucosides; Humans; Hypoglycemic Agents; Hypoxia; Metabolic Diseases; Neoplasms; Neurodegenerative Diseases; Neuroprotective Agents; Phenols; Rhodiola; Wounds and Injuries | 2020 |
SGLT2 and cancer.
Topics: Animals; Glucosides; Humans; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sodium-Glucose Transporter 2 | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Physcion and Physcion 8-O-β-D-glucopyranoside: Natural Anthraquinones with Potential Anticancer Activities.
Topics: Antineoplastic Agents; Emodin; Glucosides; Humans; Neoplasms; Signal Transduction | 2021 |
Potential Uses of Olive Oil Secoiridoids for the Prevention and Treatment of Cancer: A Narrative Review of Preclinical Studies.
Topics: Aldehydes; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Cyclopentane Monoterpenes; Diet, Mediterranean; Glucosides; Humans; Iridoid Glucosides; Iridoids; Neoplasms; Olive Oil; Phenols; Phenylethyl Alcohol; Pyrans | 2021 |
Lack of potential carcinogenicity for steviol glycosides - Systematic evaluation and integration of mechanistic data into the totality of evidence.
Topics: Animals; Carcinogenicity Tests; Diterpenes, Kaurane; Dose-Response Relationship, Drug; Glucosides; Neoplasms; Species Specificity | 2021 |
Salidroside: A review of its recent advances in synthetic pathways and pharmacological properties.
Topics: Animals; Central Nervous System; Diabetes Mellitus; Glucosides; Humans; Neoplasms; Phenols; Rhodiola | 2021 |
SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials.
Topics: Benzhydryl Compounds; Canagliflozin; Diabetes Mellitus, Type 2; Glucosides; Humans; Hypoglycemic Agents; Neoplasms; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors | 2017 |
Natural Aristolochia Alkaloid Aristololactam-β-D-glucoside: Interaction with Biomacromolecules and Correlation to the Biological Perspectives.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Aristolochia; Aristolochic Acids; Biological Products; Cell Proliferation; Glucosides; Humans; Macromolecular Substances; Neoplasms; Thermodynamics | 2018 |
Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits.
Topics: Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Bone and Bones; Canagliflozin; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Glucosides; Humans; Hypoglycemic Agents; Ketosis; Kidney; Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Weight Loss | 2018 |
Phytotherapic use of the Crocus sativus L. (Saffron) and its potential applications: A brief overview.
Topics: Alzheimer Disease; Animals; Atherosclerosis; Carotenoids; Crocus; Cyclohexenes; Depression; Glucosides; Humans; Neoplasms; Phytotherapy; Plant Extracts; Sexual Dysfunction, Physiological; Terpenes; Vitamin A | 2018 |
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials.
Topics: Adult; Aged; Benzhydryl Compounds; Diabetes Mellitus; Female; Glucosides; Humans; Hypoglycemic Agents; Incidence; Male; Middle Aged; Neoplasms; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
Dietary Flaxseed as a Strategy for Improving Human Health.
Topics: alpha-Linolenic Acid; Animals; Anti-Inflammatory Agents; Antioxidants; Brain; Butylene Glycols; Cardiovascular Diseases; Diet; Dietary Fiber; Dietary Supplements; Fatty Acids, Omega-3; Female; Flax; Functional Food; Gastrointestinal Diseases; Glucosides; Hormones; Humans; Lignans; Lipid Metabolism; Neoplasms; Seeds | 2019 |
Health effects with consumption of the flax lignan secoisolariciresinol diglucoside.
Topics: Animals; Antioxidants; Butylene Glycols; Cardiovascular Diseases; Diabetes Mellitus; Diet; Enzyme Activators; Enzyme Inhibitors; Female; Flax; Glucosides; Humans; Lignin; Neoplasms; Phytoestrogens; Pregnancy | 2010 |
Aspirin: a history, a love story.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Benzyl Alcohols; Cardiovascular Diseases; Drug Hypersensitivity; Drug Resistance; Glucosides; History, 18th Century; History, 19th Century; History, 20th Century; Humans; Neoplasms; Salix; Sex Characteristics | 2012 |
Discovery of antitumor indolocarbazoles: rebeccamycin, NSC 655649, and fluoroindolocarbazoles.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Carbazoles; Drug Design; Glucosides; Humans; Indoles; Neoplasms; Structure-Activity Relationship | 2002 |
[Experimental analysis of therapeutic properties of Rhodiola rosea L. and its possible application in medicine].
Topics: Adaptation, Physiological; Adult; Animals; Anti-Arrhythmia Agents; Antidepressive Agents; Antineoplastic Agents; Antioxidants; Arrhythmias, Cardiac; Central Nervous System; Clinical Trials as Topic; Depression; Glucosides; Humans; Lymnaea; Medicine, Traditional; Mental Fatigue; Neoplasms; Phenols; Phenylethyl Alcohol; Phytotherapy; Plant Extracts; Plant Preparations; Rats; Resins, Plant; Rhodiola | 2004 |
10 trial(s) available for glucose, (beta-d)-isomer and Benign Neoplasms
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1.
Topics: Adjuvants, Immunologic; Adult; Aged; Antigens, Neoplasm; Cancer Vaccines; CD4-Positive T-Lymphocytes; Drugs, Investigational; Female; Glucosides; Humans; Immunogenicity, Vaccine; Injections, Intramuscular; Lipid A; Male; Membrane Proteins; Middle Aged; Neoplasms; Recombinant Proteins; Toll-Like Receptor 4; Treatment Outcome; Vaccines, Synthetic; Young Adult | 2019 |
Topics: Active Transport, Cell Nucleus; Adolescent; Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Benzhydryl Compounds; Benzylamines; Biopsy; Blood Glucose; Blood Transfusion; Cholesterol, LDL; Combined Modality Therapy; Cyclams; Diabetes Mellitus, Type 2; Disease Progression; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Glucosides; Glycated Hemoglobin; Granulocyte Colony-Stimulating Factor; Hamstring Muscles; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Hodgkin Disease; Humans; Hydrazines; Immunohistochemistry; Insulin-Secreting Cells; Leg; Male; Middle Aged; Muscle Strength; Neoplasms; Peripheral Blood Stem Cell Transplantation; Range of Motion, Articular; Recurrence; Remission Induction; Research Design; Reverse Transcriptase Polymerase Chain Reaction; Soccer; Sodium-Glucose Transport Proteins; Sodium-Glucose Transporter 2 Inhibitors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Triazoles; Young Adult | 2015 |
A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carbazoles; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Glucosides; Humans; Male; Middle Aged; Neoplasms; Organoplatinum Compounds; Oxaliplatin | 2011 |
Phase I clinical and pharmacokinetic study of NSC 655649, a rebeccamycin analogue, given in both single-dose and multiple-dose formats.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Glucosides; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia | 2002 |
Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group study.
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Area Under Curve; Carbazoles; Child; Child, Preschool; Drug Administration Schedule; Glucosides; Hemoglobins; Humans; Infant; Metabolic Clearance Rate; Neoplasms; Neutropenia; Patient Selection; Platelet Count | 2003 |
Phase I and pharmacokinetic study of sequences of the rebeccamycin analogue NSC 655649 and cisplatin in patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Antineoplastic Combined Chemotherapy Protocols; Carbazoles; Cisplatin; Drug Interactions; Female; Glucosides; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia; Tomography, X-Ray Computed | 2005 |
A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group study.
Topics: Adolescent; Adult; Aminoglycosides; Antibiotics, Antineoplastic; Bone Marrow Diseases; Carbazoles; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Female; Glucosides; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Neoplasm Proteins; Neoplasms; Pancreatitis; Rhabdomyosarcoma; Salvage Therapy; Topoisomerase II Inhibitors | 2008 |
Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Cholangiocarcinoma; Disease Progression; Dose-Response Relationship, Drug; Female; Gallbladder Neoplasms; Glucosides; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia | 2001 |
Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory properties.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Dose-Response Relationship, Drug; Female; Glucosides; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia | 2001 |
83 other study(ies) available for glucose, (beta-d)-isomer and Benign Neoplasms
| Article | Year |
|---|---|
The possible role of the properdin system in transplantable cancer; the effect of zymosan on transplantable human carcinoma.
Topics: Carcinoma; Humans; Immunity; Neoplasms; Polysaccharides; Properdin; Serum Globulins; Yeasts; Zymosan | 1956 |
The ineffectiveness of zymosan in altering the heterotransplantation of tumors to rats.
Topics: Animals; Neoplasms; Neoplasms, Experimental; Polysaccharides; Rats; Yeasts; Zymosan | 1958 |
Stimulation of host defense against experimental cancer. I. Zymosan and sarcoma 180 in mice.
Topics: Animals; Mice; Neoplasms; Polysaccharides; Sarcoma 180; Yeasts; Zymosan | 1958 |
[Effects of zymosan on tumor growth in experimental animals].
Topics: Animals; Neoplasms; Neoplasms, Experimental; Polysaccharides; Yeasts; Zymosan | 1958 |
Stimulation of host defense against experimental cancer. II. Temporal and reversal studies of the zymosan effect.
Topics: Humans; Neoplasms; Polysaccharides; Research; Yeasts; Zymosan | 1959 |
[Inhibiting effect of zymosan on transplanted tumor growth in mice].
Topics: Animals; Mice; Neoplasms; Neoplasms, Experimental; Polysaccharides; Zymosan | 1960 |
[Effect of Zymosan on the properdin level of tumor patients].
Topics: Humans; Neoplasms; Polysaccharides; Properdin; Zymosan | 1961 |
[Influencing of the serum properdin levels of patients with neoplasms by parenteral administration of zymosan].
Topics: Hematologic Diseases; Humans; Neoplasms; Polysaccharides; Properdin; Zymosan | 1960 |
[Clinical experiences with Mannozym therapy in a social welfare clinic].
Topics: Ambulatory Care Facilities; Humans; Mannans; Neoplasms; Properdin; Social Welfare; Zymosan | 1963 |
The effect of yeast polysaccharides on mouse tumors.
Topics: Animals; Antineoplastic Agents; Carcinoma, Krebs 2; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; Neoplasms; Polysaccharides; Rhabdomyosarcoma; Sarcoma 180; Sarcoma 37; Yeasts; Zymosan | 1963 |
RETICULOENDOTHELIAL SYSTEM AND NEOPLASMA.
Topics: Animals; Antibodies; Bacteriophages; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Colonic Neoplasms; Lung Neoplasms; Mice; Mononuclear Phagocyte System; Neoplasms; Neoplasms, Experimental; Pancreatic Neoplasms; Properdin; Rectal Neoplasms; Research; Skin Transplantation; Stomach Neoplasms; Tetanus Toxoid; Tuberculin Test; Zymosan | 1964 |
[PREVENTION OF THE CONSEQUENCES OF TUMOR CELL DISSEMINATION IN BROWN-PEARCE TESTICULAR TUMOR IN RABBITS BY ADMINISTRATION OF MANNOZYM].
Topics: Animals; Antineoplastic Agents; Carcinoma, Brown-Pearce; Humans; Immune Sera; Male; Mannans; Neoplasms; Neoplasms, Experimental; Rabbits; Research; Testicular Neoplasms; Zymosan | 1964 |
[PREVENTION OF THE RECURRENCE OF CANCER].
Topics: Animals; Biomedical Research; Genetic Diseases, X-Linked; Hormones; Leukemia, Hairy Cell; Lymphatic Diseases; Mice; Mitomycin; Mitomycins; Mononuclear Phagocyte System; Mycobacterium bovis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Rats; Research; Severe Combined Immunodeficiency; Surgical Procedures, Operative; Thiotepa; Zymosan | 1964 |
ACQUIRED RESISTANCE AGAINST THE GROWTH OF YOSHIDA SARCOMA CELLS IN DONRYU RATS.
Topics: Animals; Carcinoma, Hepatocellular; Ink; Leukemia; Leukemia, Experimental; Liver Neoplasms; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mycobacterium bovis; Neoplasms; Neoplasms, Experimental; Pharmacology; Rats; Research; Sarcoma; Sarcoma, Yoshida; Transplantation; Trypan Blue; Typhoid-Paratyphoid Vaccines; Zymosan | 1964 |
THE RELATION BETWEEN THE RETICULOENDOTHELIAL SYSTEM AND THE SPREAD OF CANCER, ESPECIALLY OF GASTRIC CARCINOMA.
Topics: Animals; Carcinoma 256, Walker; Genetic Diseases, X-Linked; Leukemia, Hairy Cell; Lymphatic Diseases; Lymphatic Metastasis; Mononuclear Phagocyte System; Neoplasms; Neoplasms, Experimental; Phagocytosis; Pharmacology; Rats; Research; Severe Combined Immunodeficiency; Stomach Neoplasms; Zymosan | 1964 |
CHEMOTHERAPEUTIC CURE OF SPONTANEOUS MOUSE CANCER.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Cortisone; Humans; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mercaptopurine; Mice; Neoplasms; Neoplasms, Experimental; Nitrogen Mustard Compounds; Pharmacology; Puromycin; Research; Sarcoma 180; Uracil Mustard; Zymosan | 1964 |
HOST DEFENCE AND CHEMOTHERAPY IN EXPERIMENTAL CANCER.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Dactinomycin; Flavonoids; Lymphoma; Lymphoma, Non-Hodgkin; Mice; Mitomycin; Mitomycins; Mononuclear Phagocyte System; Neoplasms; Neoplasms, Experimental; Pharmacology; Polysaccharides; Rabbits; Research; Sarcoma 180; Trypan Blue; Zymosan | 1964 |
[OBSERVATION ON TUMORAL IMMUNITY IN CONNECTION WITH THE PROPERDIN SYSTEM].
Topics: Animals; Carcinoma; Carcinoma, Brown-Pearce; Lagomorpha; Neoplasms; Pharmacology; Properdin; Rabbits; Research; Zymosan | 1964 |
AGING AND CANCERIGENESIS. II. EFFECT OF AGE ON PHAGOCYTIC ACTIVITY OF THE RETICULOENDOTHIAL SYSTEM AND ON TUMOR GROWTH.
Topics: Aging; Animals; Carcinoma; Carcinoma, Ehrlich Tumor; Mice; Mononuclear Phagocyte System; Neoplasms; Pharmacology; Research; Zymosan | 1965 |
Heterotransplantation of tumours--Part II. Heterotransplantation of Walker 256 carcinoma in hamster treated with cortisone, antigen, antiserum and zymosan.
Topics: Animals; Antigens; Cortisone; Cricetinae; Immune Sera; Neoplasms; Neoplasms, Experimental; Polysaccharides; Zymosan | 1959 |
Role of phagocytic cells in cancer.
Topics: Anaerobiosis; Antineoplastic Agents; Breast Neoplasms; Complement Activation; Dinitrochlorobenzene; Humans; Kidney Neoplasms; Leukocytes; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Regression, Spontaneous; Neoplasm Transplantation; Neoplasms; Opsonin Proteins; Phagocytes; Prognosis; Radiation Injuries; Transplantation, Autologous; Zymosan | 1981 |
Simultaneous three color and electronic cell volume analysis with a single UV excitation source.
Topics: Color; Flavonoids; Flow Cytometry; Humans; Leucyl Aminopeptidase; Macrophages; Monocytes; Neoplasms; Staining and Labeling; Ultraviolet Rays; Zymosan | 1983 |
Measurement of chemiluminescence in freshly drawn human blood. II. Clinical application of zymosan-induced chemiluminescence.
Topics: Blood; Circadian Rhythm; Erythrocyte Count; Humans; Inflammation; Luminescent Measurements; Luminol; Neoplasms; Phagocytes; Zymosan | 1982 |
[Agglutination titer of isoagglutinins in blood serum in cases of malignant neoplasms following zymosan stimulation].
Topics: Humans; Injections, Intravenous; Isoantibodies; Lung Neoplasms; Neoplasms; Properdin; Zymosan | 1975 |
Modification of luminol-dependent chemiluminescence reactivity of peripheral blood leukocytes from patients with lymphoreticular tumor, solid cancer, or healthy blood donors by interferon-alpha.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; In Vitro Techniques; Interferon Type I; Leukemia; Leukocytes; Luminescent Measurements; Luminol; Lymphoma; Male; Middle Aged; Neoplasms; Phagocytes; Tetradecanoylphorbol Acetate; Zymosan | 1987 |
The effect of surgery and anesthetic agents on granulocyte-chemiluminescence in whole blood.
Topics: Abdomen; Anesthesia; Ether; Gastrointestinal Diseases; Halothane; Humans; Luminescent Measurements; Neoplasms; Neutrophils; Stress, Physiological; Zymosan | 1985 |
Effects of prolonged RES stimulation on the frequency of malignant tumors and lymphomatous disorders in mice.
Topics: Animals; Autopsy; Lymphoma; Mice; Mice, Inbred BALB C; Mononuclear Phagocyte System; Neoplasms; Phagocytosis; Zymosan | 1973 |
[Serum seromucoid levels in patients with neoplasms and in cases of radiation-induced necrosis following non-specific stimulation with zymosan].
Topics: Adult; Aged; Humans; Middle Aged; Mucoproteins; Necrosis; Neoplasms; Orosomucoid; Radiation Injuries; Radiotherapy; Zymosan | 1973 |
[Effect of zymosan on the peripheral blood picture (clinical cases)].
Topics: Cyclophosphamide; Hematopoiesis; Humans; Leukocytes; Neoplasms; Thiotepa; Zymosan | 1968 |
[Effect of non-specific stimulation with zymosan on serum properdin level in patients with neoplasms].
Topics: Blood Donors; Humans; Neoplasms; Properdin; Zymosan | 1972 |
[On the success of a combination therapy for malignant tumors, supplemented by a biologically active polysaccharide (Mannozym)].
Topics: Humans; Neoplasms; Zymosan | 1968 |
Multiple mechanisms of salidroside on anti-tumor effects.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Differentiation; Glucosides; Humans; Neoplasms; Phenols; Signal Transduction | 2021 |
Two new eudesmane sesquiterpene glucosides from the aerial parts of
Topics: Artemisia; Glucosides; Humans; Molecular Structure; Neoplasms; Plant Components, Aerial; Sesquiterpenes; Sesquiterpenes, Eudesmane | 2023 |
A novel PHD2 inhibitor acteoside from Cistanche tubulosa induces skeletal muscle mitophagy to improve cancer-related fatigue.
Topics: Animals; Cistanche; Glucosides; Mice; Mitophagy; Molecular Docking Simulation; Muscle, Skeletal; Neoplasms; Phenols; Protein Kinases; Ubiquitin-Protein Ligases | 2022 |
Steviol glycosides affect functional properties and macromolecular expression of breast cancer cells.
Topics: Diterpenes, Kaurane; ErbB Receptors; Estrogen Receptor alpha; Estrogen Receptor beta; Glucosides; Glycosides; Matrix Metalloproteinase 14; Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptors, Estrogen; RNA, Messenger | 2022 |
In-Silico Analysis of Phytocompounds of
Topics: Antineoplastic Agents; Glucosides; Humans; Luteolin; Micronutrients; Molecular Docking Simulation; Neoplasms; Olea; Plant Extracts; Pyruvate Kinase; Pyruvic Acid; Rutin | 2022 |
Screening out Biomarkers of
Topics: alpha-Linolenic Acid; Anti-Inflammatory Agents; Apigenin; Chlorogenic Acid; Glucosides; Humans; Kaempferols; Neoplasms; Quinic Acid; Vitaceae | 2023 |
Cinnamic acids as promising bioactive compounds for cancer therapy by targeting MAPK3: a computational simulation study.
Topics: Caffeic Acids; Chlorogenic Acid; Glucosides; Humans; Neoplasms; Rosmarinic Acid | 2023 |
Glucoside Derivatives Of Podophyllotoxin: Synthesis, Physicochemical Properties, And Cytotoxicity.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Glucosides; Humans; Inhibitory Concentration 50; Neoplasms; Podophyllotoxin; Structure-Activity Relationship | 2019 |
Development of a deep-red fluorescent glucose-conjugated bioprobe for in vivo tumor targeting.
Topics: Animals; Benzylidene Compounds; Biosensing Techniques; Cell Line, Tumor; Female; Fluorescence; Fluorescent Dyes; Glucose; Glucose Transporter Type 1; Glucosides; Humans; Mice, Nude; Mitochondria; Neoplasms | 2020 |
Multiple Targets Directed Multiple Ligands: An In Silico and In Vitro Approach to Evaluating the Effect of Triphala on Angiogenesis.
Topics: Angiogenesis Inhibitors; Benzopyrans; Cell Movement; Computer Simulation; Disease Progression; Enzyme-Linked Immunosorbent Assay; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Hydrolyzable Tannins; Ligands; Medicine, Ayurvedic; Molecular Docking Simulation; Neoplasms; Neovascularization, Pathologic; Plant Extracts; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2020 |
Challenges in the Discovery of Novel Therapeutic Agents in Cancer.
Topics: Antineoplastic Agents; Benzhydryl Compounds; Drug Discovery; Drug Resistance, Neoplasm; Glucosides; Neoplasms; Precision Medicine | 2019 |
Selective cytotoxic activity of isolated compounds from Globimetula dinklagei and Phragmanthera capitata (Loranthaceae).
Topics: A549 Cells; Caco-2 Cells; Caspase 3; Caspase 7; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Glucosides; HeLa Cells; Humans; Inhibitory Concentration 50; Loranthaceae; MCF-7 Cells; Neoplasms; Pentacyclic Triterpenes; Plant Extracts; Structure-Activity Relationship | 2020 |
Miyabeacin: A new cyclodimer presents a potential role for willow in cancer therapy.
Topics: Antineoplastic Agents, Phytogenic; Benzyl Alcohols; Biosynthetic Pathways; Cell Line, Tumor; Drug Screening Assays, Antitumor; Glucosides; Humans; Inhibitory Concentration 50; Neoplasms; Plant Bark; Salix | 2020 |
Injectable corilagin/low molecular weight chitosan/PLGA-PEG-PLGA thermosensitive hydrogels for localized cancer therapy and promoting drug infiltration by modulation of tumor microenvironment.
Topics: Animals; Chitosan; Glucosides; Hydrogels; Hydrolyzable Tannins; Mice; Molecular Weight; Neoplasms; Polyesters; Polyethylene Glycols; Tumor Microenvironment | 2020 |
Reaction coupling separation for isosteviol production from stevioside catalyzed by acidic ion-exchange resin.
Topics: Antineoplastic Agents; Catalysis; Diterpenes, Kaurane; G2 Phase; Glucosides; HCT116 Cells; Hep G2 Cells; Humans; Ion Exchange Resins; Neoplasms; Prodrugs | 2021 |
Development of GLUT1-targeting alkyl glucoside-modified dihydroartemisinin liposomes for cancer therapy.
Topics: Artemisinins; Cell Line, Tumor; Glucose Transporter Type 1; Glucosides; Humans; Liposomes; Neoplasms | 2020 |
Effect of dapagliflozin and/or L-arginine on solid tumor model in mice: The interaction between nitric oxide, transforming growth factor-beta 1, autophagy, and apoptosis.
Topics: Animals; Apoptosis; Arginine; Autophagy; Benzhydryl Compounds; Glucosides; Male; Mice; Neoplasms; Nitric Oxide; Transforming Growth Factor beta1; Transforming Growth Factors | 2021 |
Thermal treatment of luteolin-7-O-β-glucoside improves its immunomodulatory and antioxidant potencies.
Topics: Antioxidants; Cell Proliferation; Flavones; Glucosides; Heating; Humans; Immunologic Factors; Immunotherapy; Killer Cells, Natural; Neoplasms; Nitric Oxide; Phytochemicals; Plant Extracts; Spleen | 2017 |
Effect of steviol, steviol glycosides and stevia extract on glucocorticoid receptor signaling in normal and cancer blood cells.
Topics: Adrenocorticotropic Hormone; Cell Nucleus; Cell Survival; Dexamethasone; Diterpenes, Kaurane; Gene Expression Regulation; Glucosides; Humans; Hydrocortisone; Jurkat Cells; Leukocytes, Mononuclear; Luciferases; Neoplasms; Plant Extracts; Receptors, Glucocorticoid; Response Elements; RNA, Messenger; Signal Transduction; Stevia; Tacrolimus Binding Proteins; Transcription Factors | 2018 |
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo.
Topics: Animals; Glucosephosphate Dehydrogenase; Glucosides; Humans; Male; MCF-7 Cells; Mice, Nude; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms; Pentose Phosphate Pathway; S Phase Cell Cycle Checkpoints; Stilbenes; Xenograft Model Antitumor Assays | 2018 |
Deglycosylation of wogonoside enhances its anticancer potential.
Topics: Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Flavanones; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glucosides; Glycosylation; Humans; Hydrogen Bonding; MCF-7 Cells; Microbiota; Molecular Docking Simulation; Neoplasms; Phytotherapy; Plant Extracts; Scutellaria baicalensis | 2018 |
Quercetin glucosides promote ischemia-induced angiogenesis, but do not promote tumor growth.
Topics: Angiogenesis Inducing Agents; Animals; Antioxidants; Capillaries; Cytokines; Disease Models, Animal; Glucosides; Hindlimb; Ischemia; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Mutant Strains; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Quercetin | 2013 |
Daphnane-type diterpenoid glucosides and further constituents of Euphorbia pilosa.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Diterpenes; Euphorbia; Glucosides; Humans; Neoplasms | 2014 |
Chemo-immunotherapy using saffron and its ingredients followed by E7-NT (gp96) DNA vaccine generates different anti-tumor effects against tumors expressing the E7 protein of human papillomavirus.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cancer Vaccines; Carotenoids; Cell Line, Tumor; Chlorocebus aethiops; Combined Modality Therapy; COS Cells; Crocus; Cyclohexenes; Female; Glucosides; Immunotherapy; Mice; Mice, Inbred C57BL; Neoplasms; Papillomavirus E7 Proteins; Papillomavirus Vaccines; Phytotherapy; Plant Extracts; Polyethyleneimine; Terpenes; Transformation, Genetic; Vaccination; Vaccines, DNA | 2015 |
Identification of anti-cancer targets of eco-friendly waste Punica granatum peel by dual reverse virtual screening and binding analysis.
Topics: Alkaloids; Antineoplastic Agents; Computer Simulation; Drug Discovery; Flavonoids; Fruit; Glucosides; Humans; Hydrolyzable Tannins; Lythraceae; Molecular Docking Simulation; Molecular Targeted Therapy; Neoplasms; Piperidines; Quercetin; Tannins | 2014 |
In vivo evaluation of the genetic toxicity of Rubus niveus Thunb. (Rosaceae) extract and initial screening of its potential chemoprevention against doxorubicin-induced DNA damage.
Topics: Animals; Antibiotics, Antineoplastic; Chromosome Aberrations; Comet Assay; DNA Damage; Doxorubicin; Glucosides; Male; Mice; Micronucleus Tests; Mutagens; Neoplasms; Plant Extracts; Quercetin; Rubus; Saponins; Stigmasterol; Triterpenes | 2015 |
A new cycloartane glucoside from Rhizophora stylosa.
Topics: Caspase 3; Caspase 7; Cell Line, Tumor; Glucosides; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Neoplasms; Plant Extracts; Rhizophoraceae; Triterpenes | 2014 |
Stevia rebaudiana ethanolic extract exerts better antioxidant properties and antiproliferative effects in tumour cells than its diterpene glycoside stevioside.
Topics: Antioxidants; Cell Line, Tumor; Cell Proliferation; Diterpenes, Kaurane; Glucosides; Humans; Neoplasms; Plant Extracts; Plant Leaves; Stevia | 2016 |
Synthesis and Biological Evaluation of Iodoglucoazomycin (I-GAZ), an Azomycin-Glucose Adduct with Putative Applications in Diagnostic Imaging and Radiotherapy of Hypoxic Tumors.
Topics: Animals; Cell Line, Tumor; Glucose; Glucose Transporter Type 1; Glucosides; Heterografts; Humans; Iodine Radioisotopes; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tissue Distribution; Tumor Burden; Tumor Hypoxia | 2016 |
Interaction between Mimic Lipid Membranes and Acylated and Nonacylated Cyanidin and Its Bioactivity.
Topics: Acylation; Anthocyanins; Antioxidants; Cell Membrane; Fluorescence; Glucosides; Glycosylation; Humans; Hydrophobic and Hydrophilic Interactions; Lipid Bilayers; Membrane Lipids; Molecular Structure; Neoplasms; Serum Albumin | 2016 |
Bioguided Fraction and Isolation of the Antitumor Components from
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Glucosides; Humans; Hydrolyzable Tannins; Magnetic Resonance Spectroscopy; Neoplasms; Phyllanthus | 2016 |
Cytotoxic activities of Stachys species.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cytotoxins; Female; Glucosides; Humans; Iridoid Glucosides; Iridoid Glycosides; Iridoids; Neoplasms; Phytotherapy; Plant Components, Aerial; Plant Extracts; Pyrans; Stachys | 2008 |
In vitro anticancer property of a novel thalidomide analogue through inhibition of NF-kappaB activation in HL-60 cells.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Genes, Reporter; Glucosides; HL-60 Cells; Humans; Molecular Structure; Neoplasms; NF-kappa B; Poly(ADP-ribose) Polymerases; Thalidomide; Tumor Necrosis Factor-alpha | 2009 |
Stability study of the human G-protein coupled receptor, Smoothened.
Topics: Amino Acid Substitution; Glucosides; Hedgehog Proteins; Humans; Mutation, Missense; Neoplasms; Neurodegenerative Diseases; Protein Stability; Receptors, G-Protein-Coupled; Recombinant Proteins; Saccharomyces cerevisiae; Smoothened Receptor; Surface Plasmon Resonance; Surface-Active Agents; Veratrum Alkaloids | 2010 |
Synthesis and anti-tumor activities of methyl 2-O-aryl-6-O-aryl'-D-glucopyranosides.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Glucosides; HeLa Cells; Humans; Neoplasms; Structure-Activity Relationship | 2010 |
Synthesis and evaluation of antimigratory and antiproliferative activities of lipid-linked [13]-macro-dilactones.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Glucosides; Humans; Lactones; Lipids; Neoplasms; Structure-Activity Relationship | 2010 |
Flavonoid glycosides from Microtea debilis and their cytotoxic and anti-inflammatory effects.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Flavones; Glucosides; Hep G2 Cells; Humans; Lipopolysaccharides; Macrophages; Mice; Neoplasms; Nitrites; Phytolaccaceae; Phytotherapy; Plant Components, Aerial; Plant Extracts | 2011 |
Inhibition of DNA topoisomerases I and II and cytotoxicity of compounds from Ulmus davidiana var. japonica.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cyclohexanones; Drug Discovery; Drug Screening Assays, Antitumor; Eicosanoic Acids; Flavonoids; Glucosides; Humans; Inhibitory Concentration 50; Medicine, Korean Traditional; Molecular Structure; Neoplasms; Plant Bark; Plant Extracts; Plant Roots; Spectrometry, Mass, Fast Atom Bombardment; Terpenes; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Triterpenes; Ulmus | 2010 |
Flavonoids in Scutellaria immaculata and S. ramosissima (Lamiaceae) and their biological activity.
Topics: Anti-Infective Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Apigenin; Bacteria; Biphenyl Compounds; Flavonoids; Glucosides; Glucuronates; HeLa Cells; Humans; Inhibitory Concentration 50; Luteolin; Neoplasms; Phytotherapy; Picrates; Plant Components, Aerial; Plant Extracts; Plant Roots; Scutellaria; Trypanocidal Agents; Trypanosoma brucei brucei; Yeasts | 2011 |
Triterpenes and a triterpene glucoside from Dysoxylum cumingianum.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Colchicine; Drug Resistance, Multiple; Glucosides; Humans; Meliaceae; Molecular Structure; Neoplasms; Phytotherapy; Plant Extracts; Plant Leaves; Triterpenes; Tubulin Modulators | 2011 |
Design, synthesis, and preliminary biological evaluation of 6-O-glucose-azomycin adducts for diagnosis and therapy of hypoxic tumors.
Topics: Cell Hypoxia; Cell Line, Tumor; Drug Design; Glucose Transport Proteins, Facilitative; Glucosides; Glycosides; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Misonidazole; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Radionuclide Imaging; Radiopharmaceuticals; Transcriptional Activation | 2012 |
Inhibition of DNA topoisomerases I and II of compounds from Reynoutria japonica.
Topics: Animals; Anthraquinones; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Benzyl Alcohols; Cattle; Cell Line, Tumor; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Discovery; Fallopia japonica; Glucosides; Humans; Inhibitory Concentration 50; Medicine, Korean Traditional; Neoplasms; Plant Extracts; Plant Roots; Republic of Korea; Resorcinols; Stilbenes; Topoisomerase I Inhibitors; Transition Temperature | 2012 |
Iridoids as DNA topoisomerase I poisons.
Topics: Camptothecin; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Enzyme Inhibitors; Glucosides; Humans; Iridoid Glucosides; Iridoids; Neoplasms; Pyrans; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2005 |
Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppress tumor growth in vivo.
Topics: Animals; Anthocyanins; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Lewis Lung; Cell Cycle; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Glucosides; Humans; Male; Mice; Mice, Inbred C57BL; Neoplasms; Oryza; Time Factors | 2005 |
Arctiin induces cell growth inhibition through the down-regulation of cyclin D1 expression.
Topics: Antineoplastic Agents, Phytogenic; Cell Line; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Down-Regulation; Furans; Glucosides; Humans; Neoplasms; Retinoblastoma Protein | 2008 |
Correlative imaging of hypoxia and angiogenesis in oncology.
Topics: Autoradiography; Cell Hypoxia; Glucosides; Humans; Neoplasms; Neovascularization, Pathologic; Nitroimidazoles; Oligopeptides; Positron-Emission Tomography | 2008 |
Amygdalin (Laetrile) and prunasin beta-glucosidases: distribution in germ-free rat and in human tumor tissue.
Topics: Amygdalin; Animals; beta-Glucosidase; Female; Germ-Free Life; Glucosidases; Glucosides; Glycosides; Humans; Intestinal Mucosa; Intestines; Neoplasms; Nitriles; Rats; Substrate Specificity; Tissue Distribution | 1981 |
[NB 506].
Topics: Animals; Antineoplastic Agents; Camptothecin; Carbazoles; Clinical Trials, Phase I as Topic; Drug Resistance; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Glucosides; Humans; Neoplasms; Topoisomerase I Inhibitors | 1999 |
In vivo anti-tumor activity of a novel indolocarbazole compound, J-107088, on murine and human tumors transplanted into mice.
Topics: Animals; Antineoplastic Agents; Body Weight; Breast Neoplasms; Carbazoles; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Glucosides; Humans; Indoles; Leukemia P388; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Mice, Nude; Neoplasms; Paclitaxel; Prostatic Neoplasms; Time Factors | 1999 |
Differential inhibition of human cancer cell proliferation by citrus limonoids.
Topics: Apoptosis; Benzopyrans; Benzoxepins; Breast Neoplasms; Cell Division; Citrus; DNA, Neoplasm; Female; Flow Cytometry; Glucosides; Humans; Leukemia; Limonins; Liver Neoplasms; Neoplasms; Ovarian Neoplasms; Plant Extracts; Stomach Neoplasms; Triterpenes; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2001 |
A clinical trial of the oral form of 4'-demethyl-epipodophyllotoxin-beta-D ethylidene glucoside (NSC 141540) VP 16-213.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Administration, Oral; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Female; Glucosides; Humans; Leukemia, Myeloid; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Mesothelioma; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Urinary Bladder Neoplasms | 1975 |
Medicinal protection with Chinese herb-compound against radiation damage.
Topics: Animals; Asparagine; Drugs, Chinese Herbal; Glucosides; Hemostatics; Humans; Incidence; Leukopenia; Mice; Neoplasms; Phenylpropionates; Radiation Injuries, Experimental; Radiotherapy; Sitosterols | 1990 |